<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35060553</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Differences in peripheral immune system gene expression in frontotemporal degeneration.</ArticleTitle><Pagination><StartPage>e28645</StartPage><MedlinePgn>e28645</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e28645</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000028645</ELocationID><Abstract><AbstractText>The peripheral immune system has a key pathophysiologic role in Frontotemporal degeneration (FTD). We sought a comprehensive transcriptome-wide evaluation of gene expression alterations unique to the peripheral immune system in FTD compared to healthy controls and amyotrophic lateral sclerosis.Nineteen subjects with FTD with 19 matched healthy controls and 9 subjects with amyotrophic lateral sclerosis underwent isolation of peripheral blood mononuclear cells (PBMCs) which then underwent bulk ribonucleic acid sequencing.There was increased expression in genes associated with CD19+ B-cells, CD4+ T-cells, and CD8+ T-cells in FTD participants compared to healthy controls. In contrast, there was decreased expression in CD33+ myeloid cells, CD14+ monocytes, BDCA4+ dendritic cells, and CD56+ natural killer cells in FTD and healthy controls. Additionally, there was decreased expression is seen in associated with 2 molecular processes: autophagy with phagosomes and lysosomes, and protein processing/export. Significantly downregulated in PBMCs of FTD subjects were genes involved in antigen processing and presentation as well as lysosomal lumen formation compared to healthy control PBMCs.Our findings that the immune signature based on gene expression in PBMCs of FTD participants favors adaptive immune cells compared to innate immune cells. And decreased expression in genes associated with phagosomes and lysosomes in PBMCs of FTD participants compared to healthy controls.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sawyer</LastName><ForeName>Russell P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0003-2426-1929</Identifier><AffiliationInfo><Affiliation>University of Cincinnati College of Medicine, Department of Neurology and Rehabilitation Medicine, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Emily J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>University of Cincinnati College of Medicine, Department of Neurology and Rehabilitation Medicine, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medvedovic</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, University of Cincinnati, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, University of Cincinnati, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, University of Cincinnati, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choubey</LastName><ForeName>Divaker</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, University of Cincinnati, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatz</LastName><ForeName>Rhonna S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>University of Cincinnati College of Medicine, Department of Neurology and Rehabilitation Medicine, Cincinnati, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woo</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Cincinnati College of Medicine, Department of Neurology and Rehabilitation Medicine, Cincinnati, OH.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24NS107200</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>8</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35060553</ArticleId><ArticleId IdType="pmc">PMC8772666</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000028645</ArticleId><ArticleId IdType="pii">00005792-202201210-00060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet (London, England) 2015;386:1672&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Roberts RO. Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci 2011;45:330&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3208074</ArticleId><ArticleId IdType="pubmed">21584654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandiah N, Wang V, Lin X, et al. . Cost related to dementia in the young and the impact of etiological subtype on cost. J Alzheimer Dis 2016;49:277&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">26444788</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, Kaneb HM, Dion PA, Rouleau GA. Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp Neurol 2014;262(Pt B):91&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">24780888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12370467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M. Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol 2017;134:79&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">28466142</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol 2019;137:715&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ZA, Rankin KP, Graff-Radford NR, et al. . TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry 2013;84:956&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840954</ArticleId><ArticleId IdType="pubmed">23543794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ZA, Sturm VE, Camsari GB, et al. . Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: completing the picture. Neurol Neuroimmunol Neuroinflamm 2016;3:e301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5087253</ArticleId><ArticleId IdType="pubmed">27844039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjogren M, Wallin A. Pathophysiological aspects of frontotemporal dementia--emphasis on cytoskeleton proteins and autoimmunity. Mech Ageing Dev 2001;122:1923&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">11589911</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanesi E, Bonvicini C, Alberici A, et al. . Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. Neurobiol Aging 2013;34:1837&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">23419701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossu P, Salani F, Alberici A, et al. . Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J Neuroinflammation 2011;8:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3141503</ArticleId><ArticleId IdType="pubmed">21645364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjogren M, Folkesson S, Blennow K, Tarkowski E. Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications. J Neurol Neurosurg Psychiatry 2004;75:1107&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1739153</ArticleId><ArticleId IdType="pubmed">15258209</ArticleId></ArticleIdList></Reference><Reference><Citation>Galimberti D, Bonsi R, Fenoglio C, et al. . Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers. Brain Behav Immun 2015;49:182&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26021560</ArticleId></ArticleIdList></Reference><Reference><Citation>Broce I, Karch CM, Wen N, et al. . Immune-related genetic enrichment in frontotemporal dementia: an analysis of genome-wide association studies. PLoS Med 2018;15:e1002487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760014</ArticleId><ArticleId IdType="pubmed">29315334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Hernandez DG, Nalls MA, et al. . Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol 2014;13:686&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112126</ArticleId><ArticleId IdType="pubmed">24943344</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse M, Michler E, von Hoff F, et al. . Alterations in the peripheral immune system in dementia. J Alzheimer Dis 2017;58:1303&#x2013;13.</Citation></Reference><Reference><Citation>Matejuk A, Vandenbark AA, Offner H. Cross-talk of the CNS with immune cells and functions in health and disease. Front Neurol 2021;12:672455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8200536</ArticleId><ArticleId IdType="pubmed">34135852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, et al. . Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134(Pt 9):2456&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci 1994;124: (Suppl): 96&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Moncrieffe H, Bennett MF, Tsoras M, et al. . Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate. Rheumatology (Oxford) 2017;56:1542&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5850489</ArticleId><ArticleId IdType="pubmed">28582527</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, et al. . STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013;29:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrow J, Denoeud F, Frankish A, et al. . GENCODE: producing a reference annotation for ENCODE. Genome Biol 2006;7:01&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1810553</ArticleId><ArticleId IdType="pubmed">16925838</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sena Brandine G, Smith AD. Falco: high-speed FastQC emulation for quality control of sequencing data. F1000Research 2019;8:1874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845152</ArticleId><ArticleId IdType="pubmed">33552473</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLuca DS, Levin JZ, Sivachenko A, et al. . RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 2012;28:1530&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3356847</ArticleId><ArticleId IdType="pubmed">22539670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewels P, Magnusson M, Lundin S, K&#xe4;ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 2016;32:3047&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5039924</ArticleId><ArticleId IdType="pubmed">27312411</ArticleId></ArticleIdList></Reference><Reference><Citation>Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003;100:9440&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC170937</ArticleId><ArticleId IdType="pubmed">12883005</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, McCarthy DJ, Chen Y, et al. . Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat Protocols 2013;8:1765&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">23975260</ArticleId></ArticleIdList></Reference><Reference><Citation>Medvedovic M, Sivaganesan S. Bayesian infinite mixture model based clustering of gene expression profiles. Bioinformatics 2002;18:1194&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">12217911</ArticleId></ArticleIdList></Reference><Reference><Citation>Medvedovic M, Yeung KY, Bumgarner RE. Bayesian mixture model based clustering of replicated microarray data. Bioinformatics 2004;20:1222&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">14871871</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Sivaganesan S, Yeung KY, Guo J, Bumgarner RE, Medvedovic M. Context-specific infinite mixtures for clustering gene expression profiles across diverse microarray dataset. Bioinformatics 2006;22:1737&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1617036</ArticleId><ArticleId IdType="pubmed">16709591</ArticleId></ArticleIdList></Reference><Reference><Citation>Freudenberg JM, Sivaganesan S, Wagner M, Medvedovic M. A semi-parametric Bayesian model for unsupervised differential co-expression analysis. BMC Bioinformatics 2010;11:234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2876132</ArticleId><ArticleId IdType="pubmed">20459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, et al. . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich G, Sukhov V, Sergushichev A. Fast gene set enrichment analysis. bioRxiv. 2019:060012.</Citation></Reference><Reference><Citation>Mitrea C, Taghavi Z, Bokanizad B, et al. . Methods and approaches in the topology-based analysis of biological pathways. Front Physiol 2013;4:278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794382</ArticleId><ArticleId IdType="pubmed">24133454</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 2017;45:D353&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210567</ArticleId><ArticleId IdType="pubmed">27899662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, Ball CA, Blake JA, et al. . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirmal AJ, Regan T, Shih BB, Hume DA, Sims AH, Freeman TC. Immune cell gene signatures for profiling the microenvironment of solid tumors. Cancer Immunol Res 2018;6:1388&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">30266715</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Mahi N, Zhang EY, Sherman S, Yu JJ, Medvedovic M. Connectivity map analysis of a single-cell RNA-sequencing -derived transcriptional signature of mTOR signaling. Int J Mol Sci 2021;22:01&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8122562</ArticleId><ArticleId IdType="pubmed">33922083</ArticleId></ArticleIdList></Reference><Reference><Citation>Palm NW, Medzhitov R. Not so fast: adaptive suppression of innate immunity. Nat Med 2007;13:1142&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095835</ArticleId><ArticleId IdType="pubmed">17917657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Grassi M, Salvi E, et al. . A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. Neurobiol Aging 2015;36: 2904.e2913-2926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4706156</ArticleId><ArticleId IdType="pubmed">26154020</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent C, Doroth&#xe9;e G, Hunot S, et al. . Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain 2017;140:184&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382942</ArticleId><ArticleId IdType="pubmed">27818384</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartnell IJ, Blum D, Nicoll JAR, Dorothee G, Boche D. Glial cells and adaptive immunity in frontotemporal dementia with tau pathology. Brain 2021;144:724&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">33527991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallings RL, Humble SW, Ward ME, Wade-Martins R. Lysosomal dysfunction at the centre of Parkinson's disease and frontotemporal dementia/amyotrophic lateral sclerosis. Trends Neurosci 2019;42:899&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6931156</ArticleId><ArticleId IdType="pubmed">31704179</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdor R, Macian F. Autophagy and the regulation of the immune response. Pharmacol Res 2012;66:475&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3508673</ArticleId><ArticleId IdType="pubmed">23063674</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady OA, Martina JA, Puertollano R. Emerging roles for TFEB in the immune response and inflammation. Autophagy 2018;14:181&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5902167</ArticleId><ArticleId IdType="pubmed">28738171</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans CS, Holzbaur ELF. Autophagy and mitophagy in ALS. Neurobiol Dis 2019;122:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366665</ArticleId><ArticleId IdType="pubmed">29981842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham KM, Maulding K, Ruan K, et al. . TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS. eLife 2020;9:09.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7758070</ArticleId><ArticleId IdType="pubmed">33300868</ArticleId></ArticleIdList></Reference><Reference><Citation>Germic N, Frangez Z, Yousefi S, Simon HU. Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation. Cell Death Differ 2019;26:715&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6460400</ArticleId><ArticleId IdType="pubmed">30737475</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>